Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals how morbillivirus can adapt to infect humans
Scientists used ground-breaking techniques to reveal that small ruminant morbillivirus can adapt to infect human cells.

Researchers use novel techniques to identify changes

Researchers at The Pirbright Institute have used ground-breaking techniques to reveal that the small ruminant morbillivirus can adapt to infect human cells.

The study, published in the Journal of Virology, found that small ruminant morbillivirus (also known as Peste des petits ruminants (PPR)) could, through minor changes in a particular protein, overcome barriers that prevent it from entering human cells.

Researchers say the findings have important implications for monitoring virus evolution in the field, particularly during eradication campaigns.
Equally important, however, were the techniques used to identify the changes. Scientists say the method eliminated the need for live infectious virus and high containment laboratories, and meant modified live virus with potential zoonotic capability were not generated.

Dr Dalan Bailey who led the research explains: “By examining the zoonotic potential of non-human morbilliviruses we identified that PPRV cannot enter human cells because it does not have the correct attachment protein configuration to bind to the human SLAMF1 immune cell receptor. 

“However, using our existing understanding of how these proteins interact, and previous sequencing and structural studies, we were able to identify and confirm that a single amino acid in the PPRV Haemagglutinin can overcome this barrier to entry.”

He added: “It is important to note that this does not mean the virus would have the potential to cause disease in humans as there are many other factors required for the virus to successfully replicate and cause clinical symptoms, but it does indicate that these viruses have zoonotic potential given the right mutations and conditions.

“In the light of these findings we believe it is important that a sequence surveillance programme, similar to that undertaken for influenza, is introduced to monitor mutations in this region.”

The study was carried out in collaboration with the University of Glasgow, the University of Cambridge and other institutions.

 

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.